Secondary Logo

Evaluation of Omeprazole Limited Sampling Strategies to Estimate Constitutive Cytochrome P450 2C19 Activity in Healthy Adults

Erratum

Therapeutic Drug Monitoring: April 2019 - Volume 41 - Issue 2 - p 256
doi: 10.1097/FTD.0000000000000624
Erratum
Free
SDC

Received February 12, 2019

Accepted February 12, 2019

In the December 2018 issue of Therapeutic Drug Monitoring in the article "Evaluation of Omeprazole Limited Sampling Strategies to Estimate Constitutive Cytochrome P450 2C19 Activity in Healthy Adults" by Lin et al., an additional author, Ju-Seop Kang, MD, PhD, of the Department of Pharmacology & Clinical Pharmacology Lab, College of Medicine, Hanyang University, Seoul, Republic of Korea, should have been listed among the authors of the article, but was omitted at publication.

Back to Top | Article Outline

REFERENCE

Lin S, Nikanjam M, Capparelli EV, et al Evaluation of omeprazole limited sampling strategies to estimate constitutive cytochrome P450 2C19 activity in healthy adults. Ther Drug Monit. 2018;40:754–758.
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.